NeoGenomics reports plans to price public sale of 2.7 million shares

Craig-Hallum, Ladenburg Thalmann and Emerging Growth Equities assist

By Devika Patel

Knoxville, Tenn., Feb. 21 - NeoGenomics, Inc. will price a public offering of 2.7 million common shares with a 30-day greenshoe of an additional 450,000 shares, according to a preliminary prospectus supplement filed Thursday with the Securities and Exchange Commission.

Craig-Hallum Capital Group, Ladenburg Thalmann & Co. Inc. and Emerging Growth Equities, Ltd. are assisting.

Proceeds will be used for general corporate and operations purposes and to fund growth.

Based in Fort Myers, Fla., NeoGenomics is a provider of cancer-focused genetic and molecular testing services.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.